Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
Longo V, Brunetti O, Gnoni A, Licchetta A, Delcuratolo S, Memeo R, Solimando AG, Argentiero A. Longo V, et al. Among authors: brunetti o. Medicina (Kaunas). 2019 Oct 17;55(10):698. doi: 10.3390/medicina55100698. Medicina (Kaunas). 2019. PMID: 31627433 Free PMC article. Review.
Therapeutic approaches to myeloma bone disease: an evolving story.
Longo V, Brunetti O, D'Oronzo S, Dammacco F, Silvestris F. Longo V, et al. Among authors: brunetti o. Cancer Treat Rev. 2012 Oct;38(6):787-97. doi: 10.1016/j.ctrv.2012.03.004. Epub 2012 Apr 9. Cancer Treat Rev. 2012. PMID: 22494965 Review.
Bone metastases in hepatocellular carcinoma: an emerging issue.
Longo V, Brunetti O, D'Oronzo S, Ostuni C, Gatti P, Silvestris F. Longo V, et al. Among authors: brunetti o. Cancer Metastasis Rev. 2014 Mar;33(1):333-42. doi: 10.1007/s10555-013-9454-4. Cancer Metastasis Rev. 2014. PMID: 24357055 Review.
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?
Gnoni A, Santini D, Scartozzi M, Russo A, Licchetta A, Palmieri V, Lupo L, Faloppi L, Palasciano G, Memeo V, Angarano G, Brunetti O, Guarini A, Pisconti S, Lorusso V, Silvestris N. Gnoni A, et al. Among authors: brunetti o. Expert Opin Ther Targets. 2015;19(12):1623-35. doi: 10.1517/14728222.2015.1071354. Epub 2015 Jul 27. Expert Opin Ther Targets. 2015. PMID: 26212068 Review.
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
Silvestris N, Longo V, Cellini F, Reni M, Bittoni A, Cataldo I, Partelli S, Falconi M, Scarpa A, Brunetti O, Lorusso V, Santini D, Morganti A, Valentini V, Cascinu S. Silvestris N, et al. Among authors: brunetti o. Crit Rev Oncol Hematol. 2016 Feb;98:309-24. doi: 10.1016/j.critrevonc.2015.11.016. Epub 2015 Nov 23. Crit Rev Oncol Hematol. 2016. PMID: 26653573 Review.
Innovative surgical approaches for hepatocellular carcinoma.
Memeo R, de'Angelis N, de Blasi V, Cherkaoui Z, Brunetti O, Longo V, Piardi T, Sommacale D, Marescaux J, Mutter D, Pessaux P. Memeo R, et al. Among authors: brunetti o. World J Hepatol. 2016 May 8;8(13):591-6. doi: 10.4254/wjh.v8.i13.591. World J Hepatol. 2016. PMID: 27168871 Free PMC article. Review.
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue.
Longo V, Brunetti O, Gnoni A, Cascinu S, Gasparini G, Lorusso V, Ribatti D, Silvestris N. Longo V, et al. Among authors: brunetti o. Oncotarget. 2016 Sep 6;7(36):58649-58658. doi: 10.18632/oncotarget.10765. Oncotarget. 2016. PMID: 27462915 Free PMC article. Review.
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer.
Azzariti A, Porcelli L, Brunetti O, Del Re M, Longo V, Nardulli P, Signorile M, Xu JM, Calabrese A, Quatrale AE, Maiello E, Lorusso V, Silvestris N. Azzariti A, et al. Among authors: brunetti o. World J Gastroenterol. 2016 Jul 21;22(27):6287-95. doi: 10.3748/wjg.v22.i27.6287. World J Gastroenterol. 2016. PMID: 27468218 Free PMC article.
162 results